0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Drugs Market Size, Status and Forecast 2021-2027
Published Date: June 2021
|
Report Code: QYRE-Auto-4R430
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Oncology Drugs Market Size Status and Forecast 2021 2027

Global Oncology Drugs Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-4R430
Report
June 2021
125 Pages
QYResearch
Region: Global, Central & South America, North America, Europe, Asia Pacific, Middle East, Africa,
Description
Table of Content
Tables & Figures
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35.56% of their 2019 revenues. By region, North America had the highest share of income in 2019, at 43.61%.
Market Analysis and Insights: Global Oncology Drugs Market

The global Oncology Drugs market size is projected to reach US$ 354330 million by 2027, from US$ 178590 million in 2020, at a CAGR of 10.3% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Drugs market.
Global Oncology Drugs Scope and Market Size
Oncology Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
According to the type, the income of chemotherapy is the highest, reaching 51.31% in 2019.

Segment by Application

Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
According to the application, blood cancer has the highest share of revenue, more than 22 percent in 2019.

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Drugs Market Perspective (2016-2027)
2.2 Oncology Drugs Growth Trends by Regions
2.2.1 Oncology Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncology Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Oncology Drugs Industry Dynamic
2.3.1 Oncology Drugs Market Trends
2.3.2 Oncology Drugs Market Drivers
2.3.3 Oncology Drugs Market Challenges
2.3.4 Oncology Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Drugs Players by Revenue
3.1.1 Global Top Oncology Drugs Players by Revenue (2016-2021)
3.1.2 Global Oncology Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Drugs Revenue
3.4 Global Oncology Drugs Market Concentration Ratio
3.4.1 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Drugs Revenue in 2020
3.5 Oncology Drugs Key Players Head office and Area Served
3.6 Key Players Oncology Drugs Product Solution and Service
3.7 Date of Enter into Oncology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Drugs Breakdown Data by Type
4.1 Global Oncology Drugs Historic Market Size by Type (2016-2021)
4.2 Global Oncology Drugs Forecasted Market Size by Type (2022-2027)
5 Oncology Drugs Breakdown Data by Application
5.1 Global Oncology Drugs Historic Market Size by Application (2016-2021)
5.2 Global Oncology Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oncology Drugs Market Size (2016-2027)
6.2 North America Oncology Drugs Market Size by Type
6.2.1 North America Oncology Drugs Market Size by Type (2016-2021)
6.2.2 North America Oncology Drugs Market Size by Type (2022-2027)
6.2.3 North America Oncology Drugs Market Size by Type (2016-2027)
6.3 North America Oncology Drugs Market Size by Application
6.3.1 North America Oncology Drugs Market Size by Application (2016-2021)
6.3.2 North America Oncology Drugs Market Size by Application (2022-2027)
6.3.3 North America Oncology Drugs Market Size by Application (2016-2027)
6.4 North America Oncology Drugs Market Size by Country
6.4.1 North America Oncology Drugs Market Size by Country (2016-2021)
6.4.2 North America Oncology Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oncology Drugs Market Size (2016-2027)
7.2 Europe Oncology Drugs Market Size by Type
7.2.1 Europe Oncology Drugs Market Size by Type (2016-2021)
7.2.2 Europe Oncology Drugs Market Size by Type (2022-2027)
7.2.3 Europe Oncology Drugs Market Size by Type (2016-2027)
7.3 Europe Oncology Drugs Market Size by Application
7.3.1 Europe Oncology Drugs Market Size by Application (2016-2021)
7.3.2 Europe Oncology Drugs Market Size by Application (2022-2027)
7.3.3 Europe Oncology Drugs Market Size by Application (2016-2027)
7.4 Europe Oncology Drugs Market Size by Country
7.4.1 Europe Oncology Drugs Market Size by Country (2016-2021)
7.4.2 Europe Oncology Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oncology Drugs Market Size (2016-2027)
8.2 Asia-Pacific Oncology Drugs Market Size by Type
8.2.1 Asia-Pacific Oncology Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncology Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncology Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncology Drugs Market Size by Application
8.3.1 Asia-Pacific Oncology Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncology Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncology Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncology Drugs Market Size by Region
8.4.1 Asia-Pacific Oncology Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncology Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncology Drugs Market Size (2016-2027)
9.2 Latin America Oncology Drugs Market Size by Type
9.2.1 Latin America Oncology Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Oncology Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Oncology Drugs Market Size by Type (2016-2027)
9.3 Latin America Oncology Drugs Market Size by Application
9.3.1 Latin America Oncology Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Oncology Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Oncology Drugs Market Size by Application (2016-2027)
9.4 Latin America Oncology Drugs Market Size by Country
9.4.1 Latin America Oncology Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Oncology Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Drugs Market Size (2016-2027)
10.2 Middle East & Africa Oncology Drugs Market Size by Type
10.2.1 Middle East & Africa Oncology Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncology Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncology Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncology Drugs Market Size by Application
10.3.1 Middle East & Africa Oncology Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncology Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncology Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncology Drugs Market Size by Country
10.4.1 Middle East & Africa Oncology Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncology Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Drugs Introduction
11.1.4 Roche Revenue in Oncology Drugs Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Oncology Drugs Introduction
11.2.4 Celgene Revenue in Oncology Drugs Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Oncology Drugs Introduction
11.3.4 Novartis Revenue in Oncology Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Oncology Drugs Introduction
11.4.4 Bristol-Myers Squibb Revenue in Oncology Drugs Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Oncology Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Oncology Drugs Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Oncology Drugs Introduction
11.6.4 Merck & Co. Revenue in Oncology Drugs Business (2016-2021)
11.6.5 Merck & Co. Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Oncology Drugs Introduction
11.7.4 AstraZeneca Revenue in Oncology Drugs Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Oncology Drugs Introduction
11.8.4 Pfizer Revenue in Oncology Drugs Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Oncology Drugs Introduction
11.9.4 Amgen Revenue in Oncology Drugs Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Oncology Drugs Introduction
11.10.4 Eli Lilly Revenue in Oncology Drugs Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Oncology Drugs Introduction
11.11.4 AbbVie Revenue in Oncology Drugs Business (2016-2021)
11.11.5 AbbVie Recent Development
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Oncology Drugs Introduction
11.12.4 Takeda Revenue in Oncology Drugs Business (2016-2021)
11.12.5 Takeda Recent Development
11.13 Astellas
11.13.1 Astellas Company Details
11.13.2 Astellas Business Overview
11.13.3 Astellas Oncology Drugs Introduction
11.13.4 Astellas Revenue in Oncology Drugs Business (2016-2021)
11.13.5 Astellas Recent Development
11.14 Ipsen
11.14.1 Ipsen Company Details
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Oncology Drugs Introduction
11.14.4 Ipsen Revenue in Oncology Drugs Business (2016-2021)
11.14.5 Ipsen Recent Development
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Oncology Drugs Introduction
11.15.4 Sanofi Revenue in Oncology Drugs Business (2016-2021)
11.15.5 Sanofi Recent Development
11.16 Bayer
11.16.1 Bayer Company Details
11.16.2 Bayer Business Overview
11.16.3 Bayer Oncology Drugs Introduction
11.16.4 Bayer Revenue in Oncology Drugs Business (2016-2021)
11.16.5 Bayer Recent Development
11.17 Biogen Idec
11.17.1 Biogen Idec Company Details
11.17.2 Biogen Idec Business Overview
11.17.3 Biogen Idec Oncology Drugs Introduction
11.17.4 Biogen Idec Revenue in Oncology Drugs Business (2016-2021)
11.17.5 Biogen Idec Recent Development
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Oncology Drugs Introduction
11.18.4 Teva Revenue in Oncology Drugs Business (2016-2021)
11.18.5 Teva Recent Development
11.18 Otsuka
.1 Otsuka Company Details
.2 Otsuka Business Overview
.3 Otsuka Oncology Drugs Introduction
.4 Otsuka Revenue in Oncology Drugs Business (2016-2021)
.5 Otsuka Recent Development
11.20 Eisai
11.20.1 Eisai Company Details
11.20.2 Eisai Business Overview
11.20.3 Eisai Oncology Drugs Introduction
11.20.4 Eisai Revenue in Oncology Drugs Business (2016-2021)
11.20.5 Eisai Recent Development
11.21 Merck KGaA
11.21.1 Merck KGaA Company Details
11.21.2 Merck KGaA Business Overview
11.21.3 Merck KGaA Oncology Drugs Introduction
11.21.4 Merck KGaA Revenue in Oncology Drugs Business (2016-2021)
11.21.5 Merck KGaA Recent Development
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Details
11.22.2 Gilead Sciences Business Overview
11.22.3 Gilead Sciences Oncology Drugs Introduction
11.22.4 Gilead Sciences Revenue in Oncology Drugs Business (2016-2021)
11.22.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Oncology Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Targeted Therapy
    Table 4. Key Players of Immunotherapy (Biologic Therapy)
    Table 5. Key Players of Hormonal Therapy
    Table 6. Key Players of Others
    Table 7. Global Oncology Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Oncology Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Oncology Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Oncology Drugs Market Share by Regions (2016-2021)
    Table 11. Global Oncology Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Oncology Drugs Market Share by Regions (2022-2027)
    Table 13. Oncology Drugs Market Trends
    Table 14. Oncology Drugs Market Drivers
    Table 15. Oncology Drugs Market Challenges
    Table 16. Oncology Drugs Market Restraints
    Table 17. Global Oncology Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Oncology Drugs Market Share by Players (2016-2021)
    Table 19. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drugs as of 2020)
    Table 20. Ranking of Global Top Oncology Drugs Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Oncology Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Oncology Drugs Product Solution and Service
    Table 24. Date of Enter into Oncology Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Oncology Drugs Revenue Market Share by Type (2016-2021)
    Table 28. Global Oncology Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Oncology Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Oncology Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Oncology Drugs Revenue Market Share by Application (2016-2021)
    Table 32. Global Oncology Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Oncology Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 39. North America Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 40. Europe Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 45. Europe Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Oncology Drugs Market Size by Region (2016-2021) & (US$ Million)
    Table 51. Asia-Pacific Oncology Drugs Market Size by Region (2022-2027) & (US$ Million)
    Table 52. Latin America Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 57. Latin America Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 63. Middle East & Africa Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 64. Roche Company Details
    Table 65. Roche Business Overview
    Table 66. Roche Oncology Drugs Product
    Table 67. Roche Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 68. Roche Recent Development
    Table 69. Celgene Company Details
    Table 70. Celgene Business Overview
    Table 71. Celgene Oncology Drugs Product
    Table 72. Celgene Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 73. Celgene Recent Development
    Table 74. Novartis Company Details
    Table 75. Novartis Business Overview
    Table 76. Novartis Oncology Drugs Product
    Table 77. Novartis Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 78. Novartis Recent Development
    Table 79. Bristol-Myers Squibb Company Details
    Table 80. Bristol-Myers Squibb Business Overview
    Table 81. Bristol-Myers Squibb Oncology Drugs Product
    Table 82. Bristol-Myers Squibb Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 83. Bristol-Myers Squibb Recent Development
    Table 84. Johnson & Johnson Company Details
    Table 85. Johnson & Johnson Business Overview
    Table 86. Johnson & Johnson Oncology Drugs Product
    Table 87. Johnson & Johnson Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 88. Johnson & Johnson Recent Development
    Table 89. Merck & Co. Company Details
    Table 90. Merck & Co. Business Overview
    Table 91. Merck & Co. Oncology Drugs Product
    Table 92. Merck & Co. Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 93. Merck & Co. Recent Development
    Table 94. AstraZeneca Company Details
    Table 95. AstraZeneca Business Overview
    Table 96. AstraZeneca Oncology Drugs Product
    Table 97. AstraZeneca Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 98. AstraZeneca Recent Development
    Table 99. Pfizer Company Details
    Table 100. Pfizer Business Overview
    Table 101. Pfizer Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 102. Pfizer Recent Development
    Table 103. Amgen Company Details
    Table 104. Amgen Business Overview
    Table 105. Amgen Oncology Drugs Product
    Table 106. Amgen Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 107. Amgen Recent Development
    Table 108. Eli Lilly Company Details
    Table 109. Eli Lilly Business Overview
    Table 110. Eli Lilly Oncology Drugs Product
    Table 111. Eli Lilly Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 112. Eli Lilly Recent Development
    Table 113. AbbVie Company Details
    Table 114. AbbVie Business Overview
    Table 115. AbbVie Oncology Drugs Product
    Table 116. AbbVie Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 117. AbbVie Recent Development
    Table 118. Takeda Company Details
    Table 119. Takeda Business Overview
    Table 120. Takeda Oncology Drugs Product
    Table 121. Takeda Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 122. Takeda Recent Development
    Table 123. Astellas Company Details
    Table 124. Astellas Business Overview
    Table 125. Astellas Oncology Drugs Product
    Table 126. Astellas Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 127. Astellas Recent Development
    Table 128. Ipsen Company Details
    Table 129. Ipsen Business Overview
    Table 130. Ipsen Oncology Drugs Product
    Table 131. Ipsen Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 132. Ipsen Recent Development
    Table 133. Sanofi Company Details
    Table 134. Sanofi Business Overview
    Table 135. Sanofi Oncology Drugs Product
    Table 136. Sanofi Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 137. Sanofi Recent Development
    Table 138. Bayer Company Details
    Table 139. Bayer Business Overview
    Table 140. Bayer Oncology Drugs Product
    Table 141. Bayer Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 142. Bayer Recent Development
    Table 143. Biogen Idec Company Details
    Table 144. Biogen Idec Business Overview
    Table 145. Biogen Idec Oncology Drugs Product
    Table 146. Biogen Idec Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 147. Biogen Idec Recent Development
    Table 148. Teva Company Details
    Table 149. Teva Business Overview
    Table 150. Teva Oncology Drugs Product
    Table 151. Teva Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 152. Teva Recent Development
    Table 153. Otsuka Company Details
    Table 154. Otsuka Business Overview
    Table 155. Otsuka Oncology Drugs Product
    Table 156. Otsuka Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 157. Otsuka Recent Development
    Table 158. Eisai Company Details
    Table 159. Eisai Business Overview
    Table 160. Eisai Oncology Drugs Product
    Table 161. Eisai Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 162. Eisai Recent Development
    Table 163. Merck KGaA Company Details
    Table 164. Merck KGaA Business Overview
    Table 165. Merck KGaA Oncology Drugs Product
    Table 166. Merck KGaA Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 167. Merck KGaA Recent Development
    Table 168. Gilead Sciences Company Details
    Table 169. Gilead Sciences Business Overview
    Table 170. Gilead Sciences Oncology Drugs Product
    Table 171. Gilead Sciences Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
    Table 172. Gilead Sciences Recent Development
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Chemotherapy Features
    Figure 3. Targeted Therapy Features
    Figure 4. Immunotherapy (Biologic Therapy) Features
    Figure 5. Hormonal Therapy Features
    Figure 6. Others Features
    Figure 7. Global Oncology Drugs Market Share by Application: 2020 VS 2027
    Figure 8. Blood Cancer Case Studies
    Figure 9. Breast Cancer Case Studies
    Figure 10. Gastrointestinal Cancer Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Respiratory or Lung Cancer Case Studies
    Figure 13. Others Case Studies
    Figure 14. Oncology Drugs Report Years Considered
    Figure 15. Global Oncology Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Oncology Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Oncology Drugs Market Share by Regions: 2020 VS 2027
    Figure 18. Global Oncology Drugs Market Share by Regions (2022-2027)
    Figure 19. Global Oncology Drugs Market Share by Players in 2020
    Figure 20. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drugs as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Oncology Drugs Revenue in 2020
    Figure 22. Global Oncology Drugs Revenue Market Share by Type (2016-2021)
    Figure 23. Global Oncology Drugs Revenue Market Share by Type (2022-2027)
    Figure 24. North America Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Oncology Drugs Market Share by Type (2016-2027)
    Figure 26. North America Oncology Drugs Market Share by Application (2016-2027)
    Figure 27. North America Oncology Drugs Market Share by Country (2016-2027)
    Figure 28. United States Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Oncology Drugs Market Share by Type (2016-2027)
    Figure 32. Europe Oncology Drugs Market Share by Application (2016-2027)
    Figure 33. Europe Oncology Drugs Market Share by Country (2016-2027)
    Figure 34. Germany Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Oncology Drugs Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Oncology Drugs Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Oncology Drugs Market Share by Region (2016-2027)
    Figure 44. China Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Oncology Drugs Market Share by Type (2016-2027)
    Figure 52. Latin America Oncology Drugs Market Share by Application (2016-2027)
    Figure 53. Latin America Oncology Drugs Market Share by Country (2016-2027)
    Figure 54. Mexico Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Oncology Drugs Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Oncology Drugs Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Oncology Drugs Market Share by Country (2016-2027)
    Figure 60. Turkey Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Roche Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 64. Celgene Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 65. Novartis Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 67. Johnson & Johnson Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 68. Merck & Co. Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 69. AstraZeneca Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 70. Pfizer Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 71. Amgen Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 72. Eli Lilly Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 73. AbbVie Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 74. Takeda Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 75. Astellas Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 76. Ipsen Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 77. Sanofi Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 78. Bayer Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 79. Biogen Idec Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 80. Teva Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 81. Otsuka Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 82. Eisai Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 83. Merck KGaA Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 84. Gilead Sciences Revenue Growth Rate in Oncology Drugs Business (2016-2021)
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Torasemide API Market Research Report 2022
Global Torasemide API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-37B11450
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Baloxavir Marboxil API Market Research Report 2022
Global Baloxavir Marboxil API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-39E11527
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-29D11405
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Chemiluminescence Immunodiagnostic Market Research Report 2022
Global Chemiluminescence Immunodiagnostic Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-18X11631
Fri Aug 12 00:00:00 UTC 2022

Add to Cart